Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Atacand Advisory Cmte. To Focus On Concomitant Use With ACE Inhibitors

Feb 23 2005

• By Andrew Kasper

Related Content

AstraZeneca's Atacand Heart Failure Indication Clears FDA Ahead Of Cmte. Review

Feb 23 2005

AstraZeneca’s Atacand For Congestive Heart Failure To Receive FDA Cmte. Review

Jan 12 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window